US Dollar vs Yen

登録してリアルタイムのチャート、分析ツール、価格を入手してください。

ホーム
投資
株式
イギリス
LSE
Biofrontera AG (0DOL) 銘柄情報

Biofrontera AG (0DOL)

2.875

0.00

(0.00%)

終了 6月12日 12:30AM

Biofrontera AG (0DOL) 銘柄情報

ポートフォリオを強化: リアルタイムのディスカッションと実用的な取引アイデア。

プレミアム

通貨

2.875

( - )

買値

2.805

売値

2.945

出来高

0.00

0.00 日の範囲 0.00

2.875 52 週間の範囲 2.875

時価総額

前日終値

2.875

始値

-

時刻

最終取引時間

財務取引量

-

VWAP

-

平均取引量 (3 か月)

1,113 €

発行済株式数

6,076,862

配当利回り

PER

-2.23

1 株当たり利益 (EPS)

-0.4

歳入

13.63M

純利益

-2.44M

Biofrontera AG, a biopharmaceutical company, engages in the research, development, and distribution of dermatological products and medical products in Germany, Spain, the United Kingdom, rest of Europe, the United States, and internationally. The company offers Ameluz and BF-RhodoLED lamp for the tr... Biofrontera AG, a biopharmaceutical company, engages in the research, development, and distribution of dermatological products and medical products in Germany, Spain, the United Kingdom, rest of Europe, the United States, and internationally. The company offers Ameluz and BF-RhodoLED lamp for the treatment of mild and moderate actinic keratoses on the face and scalp, field cancerization, and fatal squamous cell carcinoma. The company also provides RhodoLED XL lamp for the treatment of multiple interspersed lesions; and Belixos, a cosmetic product for irritated and sensitive skin. In addition, the company focus on photodynamic therapy (PDT) for the treatment of actinic keratosis and keratinocyte skin cancers, including basal cell carcinoma. The company has a license and supply agreement with Maruho Co., Ltd. Biofrontera AG was founded in 1997 and is headquartered in Leverkusen, Germany. 詳細を表示

セクター

-

業界

-

ウェブサイト

www.biofrontera.com

本社

Leverkusen, Germany

設立

1997

Biofrontera AG is listed in the sector of the ロンドン証券取引所 with ticker 0DOL. The last closing price for Biofrontera was 2.88 €. Over the last year, Biofrontera shares have traded in a share price range of 2.875 € to 2.875 €.

Biofrontera currently has 6,076,862 shares in issue. The market capitalisation of Biofrontera is 17.47 € million. Biofrontera has a price to earnings ratio (PE ratio) of -2.23.

表示するニュースはありません。

期間 †	前日比	前日比 %	始値	高値	安値	平均出来高	VWAP
1	0	0	0	0	0	0	0	DE
4	0	0	0	0	0	0	0	DE
12	0	0	2.875	2.875	2.875	0	0	DE
26	0	0	2.875	2.875	2.875	0	0	DE
52	0	0	2.875	2.875	2.875	0	2.875	DE
156	0	0	2.875	60.375	2.875	0	2.875	DE
260	0	0	2.875	60.375	2.875	5	2.875	DE

0DOL - Frequently Asked Questions (FAQ)

What is the current Biofrontera AG share price?

The current share price of Biofrontera AG is 2.875 €

How many Biofrontera AG shares are in issue?

Biofrontera AG has 6,076,862 shares in issue

What is the market cap of Biofrontera AG?

The market capitalisation of Biofrontera AG is EUR 17.47M

What is the 1 year trading range for Biofrontera AG share price?

Biofrontera AG has traded in the range of 2.875 € to 2.875 € during the past year

What is the PE ratio of Biofrontera AG?

The price to earnings ratio of Biofrontera AG is -2.23

What is the cash to sales ratio of Biofrontera AG?

The cash to sales ratio of Biofrontera AG is 1.1

What is the registered address of Biofrontera AG?

The registered address for Biofrontera AG is Hemmelrather Weg 201, Leverkusen, North Rhine-Westphalia, 51377

What is the Biofrontera AG website address?

The website address for Biofrontera AG is www.biofrontera.com

BigBadWolf

BigBadWolf 2分前

The broker looks at the ledger and sees it actively bleeding out an extra 297 million shares due to the $0.05 prepaid warrant drawings and debt conversions. They refuse to submit the paperwork because the capital structure is a moving target. Now because the un-split public float has expanded to $1,

Vexari

After exposing what many are calling

The crime of the century

https://lionessofjudah.substack.com/p/breaking-pfizer-whistleblower-found?triedRedirect=true

doccjc

Some here are true longs who actually own shares.
Some are here to bash and pretend to own shares.
24 days or less until the IDE decision.
I like our odds for an approval.

SmallCapStockAlert

SmallCapStockAlert 2分前

Share repurchase sends $PPCB price soaring on high volume. https://richardacavalli.wixsite.com/greenplanetmicrocaps/ppcb-exploding-volume

waterchaser

waterchaser 2分前

Did I see trips flash here…again?

EmpressRealm45

EmpressRealm45 2分前

glad market is desensitized to this - I am sure it’s coming sometime, maybe we won’t wait for Iran war to end. Otherwise 47 wouldn’t be talking about this to press

Flip it

Flip it 2分前

This post says things are moving faster .no delays

Check out @DiddyKongRacing message on Stocktwits http://stocktwits.com/DiddyKongRacing/message/656111694

vlispxpert

vlispxpert 2分前

Nat gas dud, but scratches head as all those nat gas companies now in deep zone...makes me think something hits for nat gas to pop...rare zone wrong, guess we see

Porch Honkey

Porch Honkey 2分前

You've been Cobbed, lol.

northam43

northam43 3分前

Report #12 SPXS/SPXU Bear Cycle ends today, due to the confirmation of the 60-S-2 today during the 5th hour. This is the 9th SPXS Bear Cycle of 2026. There is an average of 12.11 SPXS Bear Cycles per year. This Bear Cycle lasted 3 trading days, the average is 21.71 trading days per cycle. Since the

DredLock

DredLock 3分前

meirluc

meirluc 4分前

I don't believe that the Mimivax trial's control arm can be used as a comparison that can be used to increase DCVax-L's QUALY reimbursement and I don't believe that this has been a reason for delaying the MHRA approval.

One reason for my skepticism is that we really don't know the re

northam43

northam43 4分前

Report #12 SPXS/SPXU Bear Cycle ends today, due to the confirmation of the 60-S-2 today during the 5th hour. This is the 9th SPXS Bear Cycle of 2026. There is an average of 12.11 SPXS Bear Cycles per year. This Bear Cycle lasted 3 trading days, the average is 21.71 trading days per cycle. Since the

vlispxpert

vlispxpert 5分前

Space recap, we bought way before the IPO filing pop, sold out "official" filing...they dipped super hard as predicted before IPO...now we ride the lightening tomorrow imo

nowwhat2

nowwhat2 5分前

Quick little follow up....LoL

https://investorshub.advfn.com/uimage/uploads/2026/6/11/mvoycignatius_follow_up_buy_rake_doh.jpg

https://investorshub.advfn.com/uimage/uploads/2026/6/11/dhofsXRP_JUNE_7_10Y_WEEKLY_W_SOL_ETH_BTC.jpg

Myth

decent volume again, I hope this means News has leaked......

I don't care what anyone says, good news here will rock this ticker, regardless of the share structure. It's that simple..

spion

TMGI penny bound +90%

price_and_volume

price_and_volume 6分前

Who's the non-stop seller? Toxic-financiers are "insiders" imo.

This type of "Insider" does enough DD to know what to expect.

They're privately informed of the basic probabilities.

They accept terms that allow them to unload at an almost guaranteed profi

spion

TMGI penny bound +90%

Jimmy Joe

Jimmy Joe 7分前

Patience dude. Nothing happens when ya want it to.
When they're ready they will disclose.

Aquahoya

Aquahoya 7分前

Thanks for sharing?

Wallstreeter$$$

Wallstreeter$$$ 7分前

Thinking all the uncertainty in the middle east has investors nerves on edge. Things should settle out in a few weeks if all goes according to this admins plan IMO.

vlispxpert

vlispxpert 8分前

MSTR +$6 since that $113 alert ;)

theRupertPupkin

theRupertPupkin 8分前

Posted on behalf of Sierra Madre Gold and Silver Ltd. — SM.v; SMDRF

Sierra Madre Gold and Silver’s Director, Jorge Monroy, and CFO, Ken Scott, recently delivered an in-depth presentation detailing the company's recent growth and the broader outlook for silver mining in Mexico.

TheBurn

TheBurn 8分前

https://x.com/NxGen_Brands/status/2065127484610511145?s=20

Xtrackers Msci Emu High ...

Cairo Resources

Papirfabrikken Invest AS

Franklin EM MultiFactor ...

American Healthcare Reit

Valeura Energy (QX)

Bond 5.25% until Oct 4th...

Sterling vs PLN

SSC Security Services (QX)

Delayed Upgrade Clock

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約

ADVFN

すでにアカウントをお持ちですか？サインイン

アカウントをお持ちでないですか？登録

登録することで、ADVFN の利用規約を読み、理解し、同意したこと、および私が個人投資家であることを確認します。